Ikena Oncology Inc reports results for the quarter ended in December - Earnings Summary

ImageneBio

17/03/2022 12:54

* Ikena Oncology Inc  IKNA.OQ  reported quarterly adjusted
earnings of 7 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 51 cents per share.
    * Revenue was $20.22 million​;  analysts expected $4.79
million. 
    * Ikena Oncology Inc's reported EPS for the quarter was 7
cents​.
    * The mean earnings estimate of analysts had risen by
about 0.6%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Ikena Oncology Inc shares had fallen by 49.7% this
quarter.
    * The company reported quarterly net income of $2.8 million.
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $27.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 17 at 12:54 p.m.  ​All
figures in US dollars unless otherwise stated